Intellectus Partners LLC Sells 1,350 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Intellectus Partners LLC cut its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 10.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,326 shares of the company’s stock after selling 1,350 shares during the period. Intellectus Partners LLC’s holdings in DocuSign were worth $673,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of DOCU. PGGM Investments grew its holdings in shares of DocuSign by 27.3% in the fourth quarter. PGGM Investments now owns 4,659 shares of the company’s stock valued at $277,000 after acquiring an additional 1,000 shares in the last quarter. Schwarz Dygos Wheeler Investment Advisors LLC bought a new stake in shares of DocuSign during the 4th quarter worth $396,000. Motley Fool Asset Management LLC purchased a new position in shares of DocuSign in the 4th quarter worth about $222,000. Syon Capital LLC increased its holdings in DocuSign by 450.2% during the fourth quarter. Syon Capital LLC now owns 550,221 shares of the company’s stock worth $32,711,000 after buying an additional 450,221 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. raised its position in DocuSign by 2.7% in the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,975 shares of the company’s stock worth $415,000 after acquiring an additional 184 shares during the period. 77.64% of the stock is currently owned by institutional investors.

Insider Transactions at DocuSign

In other DocuSign news, insider Stephen Shute sold 15,109 shares of the company’s stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $57.02, for a total value of $861,515.18. Following the completion of the sale, the insider now owns 8,959 shares of the company’s stock, valued at $510,842.18. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other DocuSign news, insider Stephen Shute sold 15,109 shares of the business’s stock in a transaction on Tuesday, March 19th. The shares were sold at an average price of $57.02, for a total value of $861,515.18. Following the completion of the sale, the insider now directly owns 8,959 shares of the company’s stock, valued at $510,842.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Teresa Briggs sold 499 shares of the company’s stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $52.99, for a total transaction of $26,442.01. Following the sale, the director now owns 6,169 shares of the company’s stock, valued at $326,895.31. The disclosure for this sale can be found here. In the last three months, insiders sold 54,871 shares of company stock worth $3,176,199. 17.80% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on DOCU. UBS Group raised shares of DocuSign from a “sell” rating to a “neutral” rating and increased their target price for the company from $48.00 to $62.00 in a research report on Friday, April 12th. JMP Securities reissued a “market outperform” rating and issued a $84.00 target price on shares of DocuSign in a research report on Friday, April 12th. Wells Fargo & Company dropped their price target on DocuSign from $55.00 to $45.00 and set an “underweight” rating on the stock in a research report on Monday, February 5th. Royal Bank of Canada reiterated a “sector perform” rating and set a $59.00 price target on shares of DocuSign in a research note on Friday, April 12th. Finally, Morgan Stanley raised shares of DocuSign from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $49.00 to $64.00 in a report on Tuesday, January 16th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $60.25.

DocuSign Price Performance

NASDAQ DOCU opened at $57.20 on Monday. The company’s 50 day simple moving average is $56.49 and its two-hundred day simple moving average is $52.80. The stock has a market capitalization of $11.75 billion, a PE ratio of 158.89, a P/E/G ratio of 4.94 and a beta of 0.89. DocuSign, Inc. has a 1 year low of $38.11 and a 1 year high of $64.76.

DocuSign (NASDAQ:DOCU) last announced its earnings results on Thursday, March 7th. The company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.06. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. The business had revenue of $712.39 million for the quarter, compared to analyst estimates of $698.05 million. On average, research analysts anticipate that DocuSign, Inc. will post 0.87 EPS for the current year.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.